Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity.

Schaible, Ulrich E; Linnemann, Lara; Redinger, Natalja; Patin, Emmanuel C; Dallenga, Tobias

Schaible, Ulrich E; Linnemann, Lara; Redinger, Natalja; Patin, Emmanuel C; Dallenga, Tobias.

Afiliación

Schaible UE; Cellular Microbiology, Priority Program Infections, Research Center Borstel, Borstel, Germany.
Linnemann L; Thematic Translation Unit Tuberculosis, German Center for Infection Research, Research Center Borstel, Borstel, Germany.
Redinger N; Cellular Microbiology, Priority Program Infections, Research Center Borstel, Borstel, Germany.
Patin EC; Cellular Microbiology, Priority Program Infections, Research Center Borstel, Borstel, Germany.
Dallenga T; Cellular Microbiology, Priority Program Infections, Research Center Borstel, Borstel, Germany.

Front Immunol ; 8: 1755, 2017.

Article en En | MEDLINE | ID: mdl-29312298

Palabras clave

CD1; IL-10; Mycobacterium tuberculosis; cell death; host-directed therapy; neutrophils; tuberculosis; vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2017 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Immunol Año: 2017 Tipo del documento: Article País de afiliación: Alemania